Lenaerts M, van der Voort L, Smidt ML, van de Weijer T, et al. The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PET. Nucl Med Commun 2026 Feb 25. doi: 10.1097/MNM.0000000000002133.
PMID: 41746946